Geneos Wealth Management’s Avantis US Equity ETF AVUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$160K Hold
1,248
– – ﹤0.01% 1072
2026
Q1
$139K Buy
1,248
+185
+17% +$21.2K ﹤0.01% 1076
2025
Q4
$119K Hold
1,063
– – ﹤0.01% 1095
2025
Q3
$116K Buy
1,063
+426
+67% +$44.7K ﹤0.01% 1075
2025
Q2
$64.2K Sell
637
-5,582
-90% -$523K ﹤0.01% 1443
2025
Q1
$575K Sell
6,219
-5,613
-47% -$547K 0.02% 582
2024
Q4
$1.15M Sell
11,832
-6,261
-35% -$615K 0.04% 387
2024
Q3
$1.72M Sell
18,093
-370
-2% -$34K 0.07% 307
2024
Q2
$1.67M Sell
18,463
-9,089
-33% -$803K 0.07% 281
2024
Q1
$2.47M Sell
27,552
-2,303
-8% -$194K 0.11% 217
2023
Q4
$2.43M Sell
29,855
-3,450
-10% -$261K 0.12% 202
2023
Q3
$2.44M Buy
33,305
+440
+1% +$33.4K 0.13% 185
2023
Q2
$2.47M Buy
32,865
+196
+0.6% +$14K 0.13% 181
2023
Q1
$2.32M Buy
+32,669
New +$2.31M 0.14% 174

Other funds holding AVUS

Geneos Wealth Management's AVUS Position: Q2 2026 in Review

Geneos Wealth Management held its Avantis US Equity ETF (AVUS) position steady in Q2 2026 at 1,248 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #1072.

Geneos Wealth Management first reported a position in AVUS in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.47M in Q2 2023. 585 funds tracked by Wall St. Rank hold AVUS as of Q2 2026.

  • Geneos Wealth Management held 1,248 shares of Avantis US Equity ETF worth $160K as of Q2 2026.
  • Geneos Wealth Management left its Avantis US Equity ETF share count unchanged in Q2 2026.
  • Avantis US Equity ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1072 holding.
  • Geneos Wealth Management first reported a position in Avantis US Equity ETF in Q1 2023 and has held it in 14 quarters since.
  • Geneos Wealth Management's Avantis US Equity ETF position peaked at $2.47M in Q2 2023.
  • 585 funds tracked by Wall St. Rank held Avantis US Equity ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.